[
  {
    "question": "Long scenario about sinusitis with DM",
    "option_a": "Mucormycosis",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In a diabetic patient presenting with sinusitis symptoms, invasive fungal infections, particularly mucormycosis, must be highly suspected. Mucormycosis is well known for its predisposition in patients with poorly controlled diabetes. The spores of mucormycosis fungi enter the nasal passages and colonize the sinuses. The hyperglycemic, acidic environment in diabetic patients favors fungal proliferation. The fungus invades local tissues and blood vessels, resulting in thrombosis, tissue infarction, and necrosis. This invasive behavior is responsible for rapid spread from the sinuses to the orbit and brain. Clinically, patients may present with acute sinusitis that rapidly evolves into more severe symptoms such as facial pain, periorbital edema, and visual disturbances. The presence of black eschars on the nasal mucosa is a distinguishing feature. The scenario typically unfolds in diabetic individuals, which elevates the clinical suspicion for mucormycosis. Differential diagnoses include bacterial sinusitis (which is far more common but less rapidly invasive), other fungal infections like aspergillosis, and neoplastic conditions. Diagnosis is supported by imaging studies (CT/MRI) showing invasion beyond the sinuses and definitive by histopathological confirmation from a tissue biopsy. Management centers on rapid surgical debridement to remove necrotic tissue along with systemic antifungal therapy using liposomal amphotericin B as the first-line treatment. In patients who are pregnant or lactating, amphotericin B is favored due to its relatively safe profile (Category B). Optimization of blood sugar levels and correction of metabolic acidosis are also critical components of management. Option A (Mucormycosis) is the correct answer given the clinical scenario of diabetic sinusitis that progresses rapidly, a pattern characteristic of invasive mucormycosis rather than a typical bacterial cause. 1. Invasive fungal sinusitis should always be considered in diabetic patients, especially if symptoms rapidly worsen. 2. Black necrotic tissue in nasal examinations is a red flag for mucormycosis. 3. Early aggressive interventions can be life-saving in cases of mucormycosis. The latest research emphasizes early surgical and antifungal management, as delays can significantly increase mortality. Recent guidelines advocate for prompt use of liposomal amphotericin B and stress strict glycemic control to improve outcomes.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Duration of acyclovir that will most likely decrease the chance of HSV recurrence:",
    "option_a": "21 days",
    "option_b": "24",
    "option_c": "14",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Herpes simplex virus (HSV) infections are characterized by their propensity for latency and recurrence. In the context of severe infections, such as HSV encephalitis, the duration of antiviral therapy is crucial for reducing the likelihood of relapse. HSV establishes latency in neuronal cells, particularly in sensory ganglia. Reactivation leads to recurrent clinical episodes. In the central nervous system, inadequate antiviral treatment duration may allow residual virus to persist, thereby increasing the risk of recurrence. For patients with HSV encephalitis or severe mucocutaneous lesions, ensuring an adequately prolonged course of antiviral therapy is important to minimize recurrence. A shorter course may not completely suppress viral replication, leading to a higher risk of relapse. Diagnosis of HSV-related conditions is typically made by PCR testing of cerebrospinal fluid (for encephalitis) or clinical examination (for mucocutaneous lesions), with differentials including varicella-zoster virus infection and other encephalitic processes. The current guidelines for treating HSV encephalitis recommend intravenous acyclovir for 21 days as first-line treatment. This duration is based on evidence that prolonged therapy reduces the incidence of viral recurrence compared to shorter regimens (like 14 days). In pregnant or lactating patients, acyclovir is generally considered safe, although dosing may need adjustment with close monitoring. Option A \u2013 21 days \u2013 is correct because multiple studies and clinical guidelines have shown that a 21-day course of acyclovir is associated with a decreased chance of HSV recurrence in severe cases, such as encephalitis. Options with shorter durations (like 14 days) may be inadequate in fully suppressing the virus. 1. HSV establishes latency, making recurrence a clinical challenge. 2. For HSV encephalitis, a 21-day course of IV acyclovir is the standard to reduce the risk of relapse. 3. Early initiation and appropriate duration of therapy are critical for optimizing outcomes. Recent clinical evidence and updated guidelines consistently support a 21-day treatment duration for HSV encephalitis to minimize recurrence risk. Ongoing research continues to evaluate optimal durations for various clinical presentations, but the 21-day course remains the standard in severe CNS infections.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of cavernous sinus thrombosis what dx:",
    "option_a": "Cavernous sinus thrombosis",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Cavernous sinus thrombosis (CST) is a serious, potentially life-threatening condition resulting from thrombosis within the cavernous sinus. It is most commonly a septic process secondary to local infections such as sinusitis, facial infections, or dental abscesses. Infections in the midface, particularly those involving the upper teeth or sinuses, can spread to the cavernous sinus via valveless facial and ophthalmic veins (including emissary veins). This leads to septic thrombosis, which can compress cranial nerves (III, IV, V1, V2, VI) that traverse the cavernous sinus and may even compromise the internal carotid artery. Patients with CST typically present with headache, fever, periorbital edema, proptosis, and ophthalmoplegia. Cranial nerve deficits (especially involving ocular movements) are key clinical findings. Given the rapid progression of the condition, prompt recognition is essential. Differential diagnoses include orbital cellulitis, carotid-cavernous fistula, and other causes of painful ophthalmoplegia. Magnetic resonance imaging (MRI) combined with magnetic resonance venography (MRV) is the preferred diagnostic modality to visualize the thrombosed cavernous sinus and assess the extent of involvement. Management requires immediate hospitalization with intravenous broad-spectrum antibiotics targeting likely pathogens (including Staphylococcus aureus, Streptococci, and anaerobes). Anticoagulation therapy may be considered on a case-by-case basis, though its use remains somewhat controversial. In the context of pregnancy and lactation, antibiotic choices must be carefully selected to ensure maternal and fetal safety, with many beta-lactams and vancomycin being acceptable options, while decisions regarding anticoagulation should be made in consultation with hematology. Option A (Cavernous sinus thrombosis) is correct based on the clinical scenario provided, where the patient\u2019s presentation aligns with the classic signs and symptoms of CST. The absence of other options in the stem reinforces that the clinical picture is intended to point to this diagnosis. 1. Early recognition and treatment of CST are critical to prevent permanent neurological deficits or death. 2. The involvement of multiple cranial nerves, particularly those controlling extraocular movements, is a hallmark of the condition. 3. A septic source from facial or sinus infections should always raise suspicion for CST. Recent guidelines and clinical studies continue to support early aggressive antibiotic therapy in CST. While the role of anticoagulation remains debated, contemporary studies suggest it may be beneficial in selected patients. Current research also focuses on improving imaging techniques for early detection and refining antimicrobial regimens to cover resistant pathogens.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about cavernous sinus thrombosis what to:",
    "option_a": "Mri with mrv",
    "option_b": "Cta",
    "option_c": "Angi",
    "option_d": "Ct orbit",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Cavernous sinus thrombosis (CST) involves clot formation within the cavernous sinus, often secondary to contiguous infections (like sinusitis or facial infections). The key diagnostic step is to visualize the venous structures and any thrombus present. In CST, an infection (commonly bacterial) spreads to the cavernous sinus, causing an inflammatory thrombotic process. The thrombus impairs venous drainage from the orbit and adjacent structures, leading to congestion and potential cranial nerve involvement. MRI along with MR venography (MRV) detects changes in the signal intensity of both the sinus and thrombus, offering high sensitivity in identifying venous occlusion. Patients typically present with headache, periorbital pain, proptosis, ophthalmoplegia (due to involvement of cranial nerves III, IV, V1, V2, and VI), and sometimes vision disturbances. These signs and symptoms, coupled with a history of local infection, prompt urgent imaging evaluation. The preferred imaging modality is MRI with MRV because it provides excellent soft tissue contrast and detailed venous imaging. Differential diagnoses include orbital cellulitis, carotid-cavernous fistula, and orbital pseudotumor. Each of these conditions has distinguishing imaging findings and clinical presentations; for example, a carotid-cavernous fistula would show abnormal arterial-venous flow on angiographic studies. Management involves immediate administration of broad-spectrum IV antibiotics to treat the underlying infection. Anticoagulation is often considered in conjunction with antibiotics, though its use remains somewhat controversial. In a pregnant or lactating patient, antibiotic selection should consider fetal and neonatal safety (for example, using agents like ceftriaxone that have established safety profiles in these populations) while still covering the likely pathogens. Supportive care and monitoring for complications are also essential. Option A (MRI with MRV) is the gold standard for diagnosing venous thrombosis in the cavernous sinus. Option B (CTA) can evaluate vascular structures but is less sensitive for venous thrombosis and soft tissue detail. Option C (Angiography) is invasive and generally reserved for vascular malformations or when interventional planning is needed. Option D (CT orbit) is mainly useful for evaluating orbital pathology and does not provide adequate assessment of the cavernous sinus. 1. MRI with MRV is the imaging modality of choice for cavernous sinus thrombosis. 2. Look for signs of ophthalmoplegia and proptosis in patients with suspected CST. 3. Early diagnosis and treatment with antibiotics (and sometimes anticoagulation) are crucial to prevent serious complications. Recent guidelines underscore the sensitivity of MRI/MRV in detecting CST and support early broad-spectrum antibiotic therapy. There is ongoing research regarding the optimal use and timing of anticoagulation in these patients.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Old female treated for herpetic neuralgia 5 days after rx became lethargic and confused ct brain and csf normal what is dx:",
    "option_a": "VZV encephalitis",
    "option_b": "Drug induced",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Cavernous sinus thrombosis (CST) involves clot formation within the cavernous sinus, often secondary to contiguous infections (like sinusitis or facial infections). The key diagnostic step is to visualize the venous structures and any thrombus present. In CST, an infection (commonly bacterial) spreads to the cavernous sinus, causing an inflammatory thrombotic process. The thrombus impairs venous drainage from the orbit and adjacent structures, leading to congestion and potential cranial nerve involvement. MRI along with MR venography (MRV) detects changes in the signal intensity of both the sinus and thrombus, offering high sensitivity in identifying venous occlusion. Patients typically present with headache, periorbital pain, proptosis, ophthalmoplegia (due to involvement of cranial nerves III, IV, V1, V2, and VI), and sometimes vision disturbances. These signs and symptoms, coupled with a history of local infection, prompt urgent imaging evaluation. The preferred imaging modality is MRI with MRV because it provides excellent soft tissue contrast and detailed venous imaging. Differential diagnoses include orbital cellulitis, carotid-cavernous fistula, and orbital pseudotumor. Each of these conditions has distinguishing imaging findings and clinical presentations; for example, a carotid-cavernous fistula would show abnormal arterial-venous flow on angiographic studies. Management involves immediate administration of broad-spectrum IV antibiotics to treat the underlying infection. Anticoagulation is often considered in conjunction with antibiotics, though its use remains somewhat controversial. In a pregnant or lactating patient, antibiotic selection should consider fetal and neonatal safety (for example, using agents like ceftriaxone that have established safety profiles in these populations) while still covering the likely pathogens. Supportive care and monitoring for complications are also essential. Option A (MRI with MRV) is the gold standard for diagnosing venous thrombosis in the cavernous sinus. Option B (CTA) can evaluate vascular structures but is less sensitive for venous thrombosis and soft tissue detail. Option C (Angiography) is invasive and generally reserved for vascular malformations or when interventional planning is needed. Option D (CT orbit) is mainly useful for evaluating orbital pathology and does not provide adequate assessment of the cavernous sinus. 1. MRI with MRV is the imaging modality of choice for cavernous sinus thrombosis. 2. Look for signs of ophthalmoplegia and proptosis in patients with suspected CST. 3. Early diagnosis and treatment with antibiotics (and sometimes anticoagulation) are crucial to prevent serious complications. Recent guidelines underscore the sensitivity of MRI/MRV in detecting CST and support early broad-spectrum antibiotic therapy. There is ongoing research regarding the optimal use and timing of anticoagulation in these patients.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Infection with Retinal whitening with orang spot.. (they did not mention macular star or neuroretinitis).",
    "option_a": "Bartonella",
    "option_b": "TB",
    "option_c": "CMV",
    "option_d": "Toxoplasmosis",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "The question describes an infectious process presenting with retinal whitening and an orange spot. In retinal infections, the pattern of lesions can help differentiate among common pathogens. Notably, neuroretinitis with a macular star is seen in Bartonella (cat\u2010scratch disease), so its absence directs attention to other causes. CMV retinitis is classically associated with retinal whitening and granular, well-demarcated borders, which can sometimes appear orange due to the active retinal necrosis. Cytomegalovirus (CMV) infects retinal cells, leading to necrosis and a localized inflammatory response. This results in retinal opacification or whitening combined with areas of hemorrhage and demarcated borders. The virus causes direct cytopathic effects, especially in immunocompromised patients, leading to characteristic retinal changes. CMV retinitis most commonly occurs in patients with immunosuppression (e.g., those with HIV/AIDS with low CD4 counts) and appears as painless vision loss with floaters. Its clinical features include areas of retinal whitening with granular borders and associated hemorrhages. The description provided fits this pattern, particularly in the absence of features like a macular star that would point toward Bartonella-induced neuroretinitis. Ophthalmologic examination with indirect fundoscopy typically demonstrates areas of retinal opacification and hemorrhage seen in CMV retinitis. Ancillary testing such as fluorescein angiography, and in some cases, polymerase chain reaction (PCR) analysis of ocular fluids, can help confirm the diagnosis. Differential considerations include ocular toxoplasmosis, TB chorioretinitis, and neuroretinitis from Bartonella infection; however, the absence of vitritis or a macular star favors CMV. The management of CMV retinitis involves prompt initiation of antiviral therapy. First-line treatments include intravenous ganciclovir or oral valganciclovir. In severe cases, intravitreal antiviral injections may be used. For pregnant patients, the use of ganciclovir and related antivirals is approached with caution due to potential teratogenic risks; treatment decisions require balancing maternal benefits against fetal risks. In lactating women, similar caution is advised because of the possibility of drug excretion in breast milk, and alternative treatment or temporary cessation of breastfeeding may be considered under specialist advice. Option A (Bartonella) typically causes neuroretinitis with an associated macular star, which is not described here. Option B (TB) can cause choroidal granulomas and retinal vasculitis but is less typically associated with a solitary retinal whitening and an orange spot appearance. Option D (Toxoplasmosis) usually presents with focal, necrotizing retinitis with vitritis (the \u201cheadlight in the fog\u201d appearance) rather than a discrete white lesion with an orange border. Option C (CMV) aligns best with the described clinical features, especially with the retinal whitening, which is a common finding in CMV retinitis. \u2022 In immunocompromised patients, especially those with HIV/AIDS, always consider CMV retinitis when retinal whitening with granular borders is observed. \n\u2022 The absence of a macular star helps exclude Bartonella-induced neuroretinitis. \n\u2022 Early ophthalmologic diagnosis and intervention are critical to prevent irreversible vision loss. Recent clinical guidelines emphasize the early diagnosis and treatment of CMV retinitis using systemic antivirals such as ganciclovir and valganciclovir. Studies support the efficacy of these treatments, along with intravitreal injections for more severe or resistant cases. Additionally, current literature stresses the importance of modifying treatment in special populations (pregnant or lactating patients) due to potential drug-related teratogenic and toxic effects.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about meningitis prophylaxis:",
    "option_a": "Rifampin",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This question tests the knowledge of prophylaxis in the context of meningococcal meningitis. Meningococcal disease is highly transmissible among close contacts via respiratory droplets. The aim of prophylaxis is to eradicate nasopharyngeal carriage in those exposed to reduce the risk of secondary cases. Neisseria meningitidis colonizes the nasopharynx and can invade the bloodstream, leading to meningitis and septicemia. Prophylactic antibiotics, such as rifampin, work by eliminating the bacteria from the carriers\u2019 upper respiratory tract, thus interrupting the transmission cycle. Close contacts of a confirmed meningococcal meningitis case (including household members, daycare contacts, or individuals with direct exposure to the patient\u2019s oral secretions) should receive prophylactic antibiotics. This intervention is crucial in preventing outbreaks in schools, military barracks, and other close-quarter settings. Diagnosis of the index case typically involves cerebrospinal fluid analysis and blood cultures. Once a case is confirmed, epidemiologic tracing identifies at-risk individuals for whom prophylaxis is indicated. Differential diagnoses include other forms of bacterial meningitis (e.g., Streptococcus pneumoniae) where prophylaxis is not routinely recommended. According to CDC and WHO guidelines, rifampin is the first-line agent for meningococcal prophylaxis in non-pregnant, non-lactating individuals. For pregnant or lactating women, alternatives such as a single intramuscular dose of ceftriaxone are preferred due to potential safety concerns with rifampin in these populations. The typical rifampin regimen is given twice daily over 2 days. Option A (Rifampin) is the standard prophylactic treatment for contacts of patients with meningococcal meningitis. Although other agents (like ciprofloxacin or ceftriaxone) exist, especially for specific patient groups such as pregnant women, rifampin remains the classic and widely accepted choice for most patients. Always consider patient-specific factors when selecting prophylaxis. While rifampin is effective, it is contraindicated or used with caution in pregnant and lactating patients. Prompt administration within 24 hours of exposure is critical to preventing secondary cases. Recent guidelines and clinical studies continue to support the use of rifampin for prophylaxis in meningococcal outbreaks. Its efficacy in eradicating nasopharyngeal carriage has been well-documented, and current protocols emphasize alternative regimens for patients in pregnancy or with other contraindications.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "What is the most common organism for bacterial meningitis: (Choices was not the organism\u2019s name, only the genre):",
    "option_a": "Pneumococcus",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis is an acute, life\u2010threatening inflammation of the meninges. In adults, Streptococcus pneumoniae (pneumococcus) is classically the most common causative agent. This organism is a Gram-positive diplococcus that frequently causes community\u2010acquired bacterial meningitis. The bacteria invade the bloodstream by various routes (e.g., from a contiguous focus such as otitis media or sinusitis) and cross the blood\u2013brain barrier. Once in the central nervous system, bacterial components induce an inflammatory cascade leading to edema, increased intracranial pressure, and neuronal injury. The pneumococcal cell wall\u2019s components are major triggers for this immune response. Patients typically present with fever, severe headache, neck stiffness, and altered mental status. Pneumococcal meningitis is associated with a rapid clinical course and significant morbidity and mortality if not promptly managed. Diagnosis is established by lumbar puncture with cerebrospinal fluid (CSF) analysis. CSF in bacterial meningitis typically shows a high neutrophil count, low glucose, and elevated protein levels. Gram staining may reveal Gram-positive diplococci, while culture confirms the diagnosis. Differential diagnoses include viral meningitis, tuberculous meningitis, and fungal meningitis, which have different CSF profiles. The management of pneumococcal meningitis involves immediate empirical antibiotic therapy \u2013 typically intravenous vancomycin plus a third-generation cephalosporin (e.g., ceftriaxone). Adjunctive dexamethasone is recommended to reduce inflammatory complications. In pregnancy and lactation, these antibiotics are generally considered safe when the benefits of treating a life-threatening infection outweigh any potential risks, although dose adjustments and careful monitoring are advised. Option A (Pneumococcus) is correct because Streptococcus pneumoniae is the predominant cause of community-acquired bacterial meningitis in adults. Had the other options been provided (likely representing other bacterial genus), they would not align with the epidemiology for this age group. \u2022 In adults, Streptococcus pneumoniae is the leading cause of bacterial meningitis. \u2022 Early recognition and treatment are crucial to prevent neurologic complications. \u2022 Dexamethasone has been shown to improve outcomes in pneumococcal meningitis when administered early. Recent guidelines from the Infectious Diseases Society of America (IDSA) emphasize rapid diagnostic evaluation and prompt initiation of broad-spectrum antibiotics with adjunctive steroids in pneumococcal meningitis. This approach has been shown to reduce morbidity and mortality.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of young with hx going with cns infection with labs and vital signs provided which showed fever and csf pleocytosis but negative c/s and gram stain, also negative for HSV PCR what is next:",
    "option_a": "Acyclovir",
    "option_b": "Paracetamol",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Viral meningitis is the most common form of meningitis overall, especially in younger individuals. It is typically self-limited and most often caused by non-herpes viruses, such as enteroviruses, rather than by HSV when the PCR is negative. Viruses infect the meninges and cause inflammation that results in a lymphocytic pleocytosis in the CSF. Unlike bacterial meningitis, the inflammatory response in viral meningitis is more subdued, resulting in a generally milder clinical course. Patients usually present with headache, fever, neck stiffness, and photophobia. The clinical picture is less dramatic than that seen in bacterial meningitis, and altered mental status is less common. The absence of bacteria on Gram stain and culture, along with a negative HSV PCR, supports a viral etiology. The diagnostic workup includes lumbar puncture with CSF analysis. CSF in viral meningitis shows a lymphocytic predominance, normal or mildly decreased glucose levels, and moderately elevated protein. Differential diagnoses include bacterial meningitis (which has neutrophilic predominance), tuberculous meningitis, and fungal meningitis. Management is primarily supportive \u2013 ensuring hydration, pain control, and fever management with agents such as paracetamol. Since HSV PCR is negative, acyclovir is not indicated. In pregnancy and lactation, paracetamol is the preferred antipyretic and analgesic due to its established safety profile. Option A (Acyclovir) would be indicated if there were clinical or laboratory evidence of HSV encephalitis, but the negative HSV PCR essentially rules out HSV involvement in this scenario. Option B (Paracetamol) is correct as supportive care is the mainstay of treatment in viral meningitis. \u2022 Viral meningitis usually follows a benign course and is managed supportively. \u2022 A negative HSV PCR helps exclude HSV encephalitis, eliminating the need for acyclovir. \u2022 Early lumbar puncture is key to differentiating viral from bacterial meningitis. Current research and clinical guidelines support that in cases of non-HSV viral meningitis, routine antiviral therapy is unnecessary, and management remains supportive. Studies continue to underscore the self-limiting nature of viral meningitis in immunocompetent individuals.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Q about pt with corona but covid \u2013ve (not clear) if it corona or meningitis. Chest x ray Rt-pcr ?",
    "option_a": "Vancomycin and ceftriaxone",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "When a patient presents with symptoms that could suggest meningitis, even amid concerns for COVID-19, it is imperative to establish whether the central nervous system is involved. Empiric treatment for bacterial meningitis should not be delayed when clinical suspicion is high. Bacterial meningitis is characterized by the invasion of bacteria into the meninges, triggering an inflammatory response that can rapidly lead to cerebral edema and increased intracranial pressure. Timely antibiotic therapy is vital to interrupt this cascade. Patients typically exhibit high fever, severe headache, neck stiffness, and sometimes altered mental status. Because the clinical signs of meningitis overlap with those of other systemic infections, thorough investigation including imaging and CSF analysis is required. The workup includes neuroimaging (if raised intracranial pressure is suspected), lumbar puncture, and CSF analysis. Concurrently, a chest X-ray and RT-PCR for COVID-19 are used to evaluate for respiratory causes. In this case, a negative COVID RT-PCR refocuses clinical concern on bacterial meningitis. Empiric antibiotic therapy is mandated in suspected bacterial meningitis. Current guidelines recommend a regimen of intravenous vancomycin plus a third-generation cephalosporin (ceftriaxone) to cover the most common pathogens. In pregnant or lactating patients, these antibiotics remain the mainstay therapy, given that the risks of untreated meningitis far outweigh potential antibiotic risks, though patient-specific risk assessments should be made. Option A (Vancomycin and ceftriaxone) is correct because it provides broad-spectrum coverage for the common bacterial pathogens, including Streptococcus pneumoniae and Neisseria meningitidis. Other options, possibly suggesting antiviral or solely supportive measures, would be inadequate if bacterial meningitis is the underlying concern. \u2022 In suspected bacterial meningitis, immediate empiric antibiotic therapy is critical to reduce mortality. \u2022 Negative RT-PCR for COVID allows clinicians to focus on the meningitis workup and management. \u2022 Always confirm the diagnosis with CSF analysis and imaging when indicated. Updated guidelines from neurocritical care and infectious diseases societies emphasize early empiric antibiotic treatment in cases of suspected meningitis. Recent literature also supports the safety and efficacy of vancomycin combined with ceftriaxone in diverse patient populations, including pregnant and lactating women, when appropriately indicated.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about HIV + patient with low CD4 count, MRI attached with multiple ring-enhancing lesion. What is the most likely responsible organism?",
    "option_a": "virus",
    "option_b": ", which is understood to represent Toxoplasma gondii, is correct given its high prevalence and characteristic imaging findings in this patient population.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV-positive patients with significantly reduced CD4 counts, the emergence of multiple ring-enhancing lesions on brain imaging is most typically due to reactivation of Toxoplasma gondii. This is the most common cause of central nervous system (CNS) mass lesions in patients with AIDS. Toxoplasma gondii is an obligate intracellular parasite that reactivates in immunocompromised individuals. The reactivated infection produces necrotic foci in the brain, leading to inflammation and the characteristic multiple ring-enhancing lesions seen on magnetic resonance imaging (MRI). Clinically, patients may present with focal neurological deficits, headache, confusion, and sometimes seizures. Although primary CNS lymphoma is an important differential in this population, multiple lesions are more suggestive of toxoplasmosis. MRI is the imaging modality of choice, showing multiple ring-enhancing lesions. Diagnosis is further supported by serologic tests (elevated Toxoplasma IgG titers) and the patient\u2019s immunocompromised status. Differential diagnoses include primary CNS lymphoma (often a single lesion or solitary dominant lesion), tuberculomas, and fungal abscesses. A therapeutic trial of antitoxoplasma therapy is often used to further confirm the diagnosis. First-line treatment for CNS toxoplasmosis is a combination of pyrimethamine, sulfadiazine, and leucovorin. In pregnant patients, treatment options are more nuanced due to potential teratogenic effects; spiramycin is often used early in pregnancy to prevent fetal transmission, with careful adjustment later if maternal treatment is required. Management in lactating women requires evaluation of drug safety profiles and close monitoring. Option A (virus) is incorrect because viruses are not typically responsible for multiple ring-enhancing lesions in HIV patients with low CD4 counts. Marked option B, which is understood to represent Toxoplasma gondii, is correct given its high prevalence and characteristic imaging findings in this patient population. \u2022 In AIDS patients, multiple ring-enhancing brain lesions are most commonly due to toxoplasmosis. \u2022 A therapeutic trial of antitoxoplasma therapy can be both diagnostic and therapeutic. \u2022 Early prophylaxis in patients with low CD4 counts (e.g., with trimethoprim-sulfamethoxazole) can prevent toxoplasmosis. Current clinical guidelines and recent studies emphasize the importance of prompt antitoxoplasma therapy in immunocompromised patients presenting with characteristic imaging findings. Ongoing research focuses on optimizing prophylactic regimens in patients with low CD4 counts to reduce opportunistic CNS infections.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of HSV encephalitis what you will find:",
    "option_a": "CSF Pleocytosis with RBC",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "HSV encephalitis is an acute viral infection of the brain most commonly caused by HSV-1. It typically targets the temporal lobes, leading to characteristic clinical and radiologic findings. The condition often presents with fever, headache, altered mental status, and seizures. HSV enters the neural tissue (via the olfactory route or hematogenous spread) and causes a necrotizing, hemorrhagic encephalitis. The virus induces an inflammatory response that disrupts the blood\u2013brain barrier, resulting in a CSF picture that may include lymphocytic pleocytosis and red blood cells from hemorrhagic necrosis. Patients tend to present with rapid onset of fever, behavioral changes, focal neurological deficits, and seizures. Temporal lobe involvement may cause memory impairment and personality changes. The presence of RBCs in the CSF reflects the hemorrhagic nature of the infection. The workup includes lumbar puncture for CSF analysis (which typically shows lymphocytic pleocytosis, mildly elevated protein, normal to slightly low glucose, and RBCs) and PCR for HSV DNA, which is the diagnostic gold standard. MRI of the brain often demonstrates hyperintense lesions in the temporal lobes. Immediate initiation of IV acyclovir is the standard first-line treatment. Supportive care and monitoring for complications are essential. In pregnancy and lactation, acyclovir is considered safe and is recommended when HSV encephalitis is strongly suspected due to the high morbidity and mortality of an untreated infection. Option A (CSF Pleocytosis with RBC) is correct because HSV encephalitis is known to produce a CSF profile with pleocytosis and occasional red blood cells due to hemorrhagic necrosis. Other options, if provided, would not align as well with these characteristic findings. \u2022 Early treatment with acyclovir significantly improves outcomes. \u2022 Temporal lobe involvement on MRI is highly suggestive of HSV encephalitis. \u2022 Always obtain CSF PCR for definitive diagnosis. Recent guidelines emphasize rapid initiation of acyclovir upon clinical suspicion and support the use of PCR for diagnostic confirmation. Studies continue to show that early treatment is crucial to reducing neurological sequelae.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of HIV pt. With PML rx?",
    "option_a": "HAART",
    "option_b": "Steroid",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Progressive Multifocal Leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by the reactivation of the JC virus, particularly in immunocompromised patients such as those with HIV. In PML, JC virus infects oligodendrocytes, leading to demyelination in multiple foci without a significant inflammatory response. This results in progressive neurological decline. Patients typically demonstrate subacute, progressive neurological deficits that may include motor weakness, visual disturbances, and cognitive impairment. Notably, the process is noninflammatory and does not present with fever or systemic signs of infection. MRI findings include multifocal areas of white matter signal abnormalities that usually do not enhance with contrast. CSF analysis may be used to detect JC virus DNA via PCR. Differential diagnoses include HIV-associated dementia and CNS lymphoma, among others. The cornerstone of therapy is immune reconstitution via highly active antiretroviral therapy (HAART). There is no direct antiviral treatment for JC virus. In pregnancy and lactation, HAART regimens are chosen based on safety profiles as recommended by current guidelines, with many antiretroviral drugs considered acceptable. Option A (HAART) is correct, as the most effective management strategy for PML is to improve the immune system function. Steroids (Option B) are not typically beneficial unless there is evidence of an immune reconstitution inflammatory syndrome (IRIS). \u2022 PML lesions typically lack contrast enhancement on MRI. \u2022 Restoration of immune function via HAART is critical in improving outcomes. \u2022 Early recognition in HIV patients is crucial since prognosis is linked to immune recovery. Recent studies support the initiation of HAART as soon as possible to control HIV replication, thereby reducing the risk of opportunistic infections such as PML. Ongoing research is focused on adjunctive therapies to directly target JC virus.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A patient came with fever and confusion, was anemic, had hypoglycemia, which was treated, CSF was given (normal) along with labs. What medication to treat:",
    "option_a": "Acyclovir",
    "option_b": "artemisinin (the one to treat cerebral malaria)",
    "option_c": "Vancomycin and ceftriaxone",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Cerebral malaria is a severe and life-threatening complication of infection with Plasmodium falciparum. It is characterized by neurological involvement and is a major cause of morbidity and mortality in endemic regions. In cerebral malaria, parasitized red blood cells adhere to the cerebral microvasculature, leading to microvascular obstruction, hypoxia, metabolic derangements, and an inflammatory cascade. Anemia and hypoglycemia are common due to parasite consumption of glucose and red cell destruction. Clinically, patients present with high fever, altered mental status, seizures, and coma. The presence of anemia and hypoglycemia in a febrile patient is highly suggestive of severe malaria. A normal CSF study is typical, which helps differentiate it from other causes of encephalopathy such as bacterial meningitis or viral encephalitis. Diagnosis is primarily based on peripheral blood smear for Plasmodium falciparum and rapid diagnostic tests. Normal CSF findings help to exclude other central nervous system infections. Differentials include viral encephalitis and bacterial meningitis, which usually present with abnormal CSF findings. The first-line therapy for cerebral malaria is intravenous artesunate, an artemisinin derivative. In pregnancy, IV artesunate is recommended for severe malaria in the second and third trimesters; however, in the first trimester, the risk versus benefit must be carefully evaluated. If artesunate is unavailable, quinine is an alternative, though it has a less favorable side-effect profile. Option B (artemisinin) is correct because artemisinin derivatives, particularly artesunate, are the treatment of choice for cerebral malaria. Option A (acyclovir) would be indicated for viral encephalitis and Option C (vancomycin and ceftriaxone) are used for bacterial meningitis, both of which are inconsistent with the clinical picture and the normal CSF findings. \u2022 A normal CSF in the presence of neurological symptoms and hypoglycemia should prompt consideration of cerebral malaria. \u2022 Intravenous artesunate has been shown to reduce mortality when initiated promptly. \u2022 Monitor blood glucose levels closely during treatment. Recent World Health Organization (WHO) guidelines reinforce the use of IV artesunate for severe malaria, demonstrating improved survival and fewer complications relative to quinine. Ongoing research focuses on optimizing treatment durations and adjunctive therapies.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "HIV patient MRI typical for Neurocystcercosis what is the cause?",
    "option_a": "Tinea solium.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is an infection of the central nervous system caused by the larval stage of Taenia solium, the pork tapeworm. It is the most common parasitic CNS infection worldwide and a leading cause of acquired epilepsy in endemic areas. Ingestion of Taenia solium eggs, usually through fecal-oral contamination, leads to the development of larvae that migrate and lodge in various tissues, particularly the brain. In the CNS, these larvae form cysts that elicit an inflammatory response, causing seizures and other neurological symptoms. The imaging hallmark is a cyst with a visible scolex. Patients with neurocysticercosis commonly present with seizures, headaches, and focal neurologic deficits. In immunocompromised patients, such as those with HIV, the presentation might be atypical or more severe due to altered immune responses. Diagnosis is based on neuroimaging (MRI is preferred over CT) showing cystic lesions often with a scolex, along with supportive serological tests. Differential diagnoses include brain abscesses, tuberculomas, and neoplasms. The presence of calcifications in chronic cases further supports the diagnosis. First-line treatment for active neurocysticercosis is with antiparasitic agents such as albendazole, usually combined with corticosteroids to reduce inflammatory response during cyst degeneration. Antiepileptic drugs are administered to control seizures. In pregnancy, treatment is challenging: antihelminthic therapy is usually deferred in the first trimester due to potential teratogenicity, and decisions must balance maternal and fetal risks. In lactating women, treatment can generally proceed, as the medications have minimal secretion in breast milk. Option A is intended to indicate the cause of neurocysticercosis. However, it states 'Tinea solium' which is a misnomer. The correct term is 'Taenia solium'. Despite the spelling error, the intended answer (the parasite) is that of Taenia solium. Other answer options were not provided, making Option A the most correct when the typographical error is corrected. \u2022 The presence of a scolex within a cyst on neuroimaging is diagnostic of neurocysticercosis. \u2022 Neurocysticercosis is a leading cause of acquired epilepsy in endemic regions. \u2022 Appropriate use of corticosteroids during antiparasitic treatment minimizes inflammatory complications. Recent guidelines advocate for combined albendazole and corticosteroid therapy in active neurocysticercosis. Current research continues to refine treatment regimens, including the optimal duration of antiparasitic therapy, and stresses careful consideration of treatment risks during pregnancy and lactation.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Flaccid weakness, JLOC, extrapyramidal symptoms:",
    "option_a": "West nile virus.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "West Nile virus is an arthropod\u2010borne (mosquito transmitted) flavivirus that can cause neuroinvasive disease. It is classically associated with encephalitis, meningitis, and a poliomyelitis-like acute flaccid paralysis. In some cases, it also causes movement disorders including parkinsonian features (extrapyramidal symptoms). After transmission by an infected mosquito bite, West Nile virus replicates in local tissues and then disseminates through the bloodstream. In a subset of patients, the virus crosses the blood\u2013brain barrier and infects neurons, leading to inflammation and neuronal injury. The involvement of anterior horn cells is responsible for the acute flaccid paralysis, while basal ganglia involvement can explain extrapyramidal manifestations. Recent studies continue to emphasize the role of host immune response in mediating neuronal injury in neuroinvasive disease. Patients with West Nile neuroinvasive disease may present with a spectrum ranging from mild meningitis to severe encephalitis with altered mental status (which may be reflected as a loss or altered level of consciousness [JLOC]) and focal neurologic deficits such as flaccid weakness. The presence of extrapyramidal signs further supports involvement of deep brain structures. Diagnosis is based on clinical manifestations, supported by laboratory studies \u2013 notably the detection of West Nile virus\u2013specific IgM in serum and cerebrospinal fluid. Differential diagnoses include Guillain\u2013Barr\u00e9 syndrome, poliomyelitis, and other viral encephalitides (e.g., St. Louis encephalitis). Neuroimaging may help rule out other causes, though findings are often nonspecific in West Nile encephalitis. There is no specific antiviral treatment for West Nile virus. Management is largely supportive and includes hospitalization, respiratory and hemodynamic support, and careful monitoring of neurological status. Rehabilitation is essential in patients with residual weakness. For pregnant and lactating patients, supportive management remains appropriate, and treatment protocols do not differ from the general population due to the lack of targeted antiviral therapies. Option A (West Nile virus) is correct because the combination of flaccid weakness, altered consciousness (JLOC), and extrapyramidal symptoms corresponds well with the neuroinvasive manifestation of West Nile virus. Other options (B, C, D) are not provided but would likely represent conditions with differing clinical and pathologic profiles. 1. West Nile virus can mimic poliomyelitis by causing acute flaccid paralysis. 2. Extrapyramidal symptoms may occur due to involvement of deep brain structures. 3. Diagnosis relies on detecting IgM antibodies in the CSF and serum. Recent guidelines and reviews emphasize the need for early recognition and supportive care in neuroinvasive West Nile virus, as no specific antiviral therapy is available. Current research continues into immune modulators and potential antiviral agents, although none have yet shown definitive benefit in clinical trials.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient has bilateral facial weakness and LP showed high WBC; pic showed Erythema migrans. What is the treatment?",
    "option_a": "Ceftriaxon",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Lyme disease, caused by the spirochete Borrelia burgdorferi transmitted by Ixodes ticks, often presents with early skin findings (erythema migrans) and may later disseminate with neurological manifestations, among which bilateral facial nerve palsy is common. After initial infection, Borrelia burgdorferi may disseminate hematogenously to various tissues including the central nervous system. In neuroborreliosis, the pathogen induces an inflammatory response within the meninges and cranial nerves, leading to lymphocytic pleocytosis in CSF and cranial neuropathies such as bilateral facial palsy. The patient\u2019s bilateral facial weakness, along with the history of erythema migrans and CSF findings of high white blood cell count, is highly suggestive of Lyme neuroborreliosis. This condition typically affects cranial nerves, most characteristically the facial nerve. The association with erythema migrans strengthens the clinical diagnosis. Diagnosis is primarily clinical (history of tick exposure, erythema migrans) supported by laboratory studies \u2013 including serologic testing for Borrelia-specific antibodies and CSF analysis showing lymphocytic pleocytosis. The differential diagnosis includes Bell\u2019s palsy (usually unilateral), Guillain\u2013Barr\u00e9 syndrome, sarcoidosis, and other infectious causes such as HIV. According to current guidelines, the first-line treatment for Lyme neuroborreliosis is intravenous ceftriaxone for 14\u201328 days. In cases involving only early localized disease, oral doxycycline could be considered; however, for meningitis or facial nerve palsies, IV therapy is preferred. For pregnant and lactating patients, ceftriaxone is safe and preferred over doxycycline, which is contraindicated because of its potential adverse effects on fetal tooth and bone development. Option A (Ceftriaxone) is correct because it is the recommended treatment for neuroborreliosis, especially when there is evidence of central nervous system involvement such as bilateral facial palsy combined with meningitic CSF findings. The other options (B, C, D) are not provided, but ceftriaxone remains the treatment of choice in this clinical scenario. 1. Bilateral facial palsy in Lyme disease is a red flag and should prompt evaluation for neuroborreliosis. 2. Erythema migrans is pathognomonic for Lyme disease. 3. IV ceftriaxone is favored in CNS involvement, especially in pregnancy. Recent guidelines from the Infectious Diseases Society of America (IDSA) and European Lyme guidelines continue to endorse IV ceftriaxone for patients with neuroborreliosis. Emerging research has not substantially altered first-line management, underscoring the importance of early recognition and prompt treatment.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "DM patient came to ER with black lesion in her nostril; what is the treatment?",
    "option_a": "Amphotricine",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Rhinocerebral mucormycosis is a rapidly progressive, angioinvasive fungal infection primarily affecting immunocompromised individuals, notably those with uncontrolled diabetes. It is characterized by tissue necrosis leading to black eschar, often in the nasal or facial region. Mucormycosis is caused by fungi of the order Mucorales. In diabetic patients, especially during episodes of diabetic ketoacidosis, high serum glucose and acidic conditions impair phagocytic function, which facilitates fungal invasion. The organisms invade blood vessel walls leading to thrombosis, tissue infarction, and necrosis, manifesting clinically as black lesions. In diabetic patients, the appearance of a black, necrotic lesion in the nasal area is a hallmark of rhinocerebral mucormycosis. The rapid progression and association with tissue necrosis require urgent recognition and intervention to prevent intracranial extension. Diagnosis is clinical but should be confirmed with imaging (CT/MRI to assess extent) and tissue biopsy with histopathological examination demonstrating broad, nonseptate hyphae with right-angle branching. Differential diagnoses include other invasive fungal infections (e.g., Aspergillus) or necrotizing bacterial infections, but the clinical context in diabetic ketoacidosis is strongly suggestive of mucormycosis. Management requires urgent and aggressive intervention: (1) Immediate initiation of high-dose liposomal amphotericin B is considered first-line therapy. (2) Surgical debridement of necrotic tissue is essential. (3) Correction of underlying metabolic abnormalities (e.g., control of blood sugar and reversal of ketoacidosis). For pregnant and lactating patients, amphotericin B is the treatment of choice due to its safety profile in these populations compared with other antifungals. Option A (Amphotericin) is correct because amphotericin B (preferably liposomal formulation) is the mainstay of therapy for mucormycosis. Other options, which are not provided here, would not adequately cover this aggressive fungal infection. Note that surgical intervention complements medical therapy. 1. A black necrotic lesion in the nasal region of a diabetic patient is highly suspicious for mucormycosis. 2. Early diagnosis and prompt combined surgical and antifungal management are critical to improving survival. 3. Liposomal amphotericin B is preferred due to its improved safety profile. Recent studies and consensus guidelines continue to support the combination of surgical debridement and high-dose liposomal amphotericin B as the mainstay of treatment. Ongoing research is evaluating newer antifungal agents and combination therapies, but early aggressive management remains key to favorable outcomes.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with encephalopathy, EEG showed: slow bilateral synchronous high amplitude spike spike:",
    "option_a": "Measles.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Subacute sclerosing panencephalitis (SSPE) is a rare, progressive, and ultimately fatal encephalopathy resulting from a persistent measles virus infection. It typically occurs several years after the initial measles infection and is characterized by cognitive decline and myoclonic jerks, with a classic periodic EEG pattern. Following an incomplete immune clearance of measles virus, the virus persists in the brain and elicits a chronic inflammatory response. This leads to progressive demyelination, neuronal degeneration, and the formation of characteristic periodic EEG complexes (high amplitude slow spike-and-wave discharges). The pathogenesis involves both direct viral damage and immune-mediated injury. Patients with SSPE present with progressive cognitive deterioration, behavioral changes, myoclonus, and other motor abnormalities. The EEG typically shows bilateral, synchronous high-amplitude periodic complexes, a hallmark of the disease, which correlates with the fluctuating clinical course. Diagnosis combines clinical history (often childhood measles infection), neuroimaging, characteristic EEG findings, and laboratory studies (elevated measles antibody titers in the CSF). Differential diagnoses include other causes of encephalopathy such as Creutzfeldt-Jakob disease, autoimmune encephalitis, and other post-infectious encephalitides. Currently, there is no curative therapy for SSPE, and management is largely supportive. Some studies have explored antiviral agents (such as intraventricular interferon-alpha) and immunomodulatory therapies, but none have consistently altered the disease course. In pregnant and lactating patients, treatment remains supportive as no effective, safe therapies are available. Preventative measures, especially measles vaccination, remain the most effective strategy. Option A (Measles) is correct in that the described EEG findings are classic for SSPE, a complication secondary to measles infection. Although the term \u2018SSPE\u2019 is more precise, the option \u2018Measles\u2019 is acceptable as it represents the underlying etiologic agent. Other options (B, C, D) are not provided here, but none would fit the classic EEG pattern and clinical picture as well as measles does. 1. SSPE is a delayed but fatal complication of measles, underscoring the importance of measles vaccination. 2. The classic EEG periodic high amplitude complexes in SSPE are nearly pathognomonic when taken with the clinical history. 3. There is currently no curative treatment for SSPE; management is supportive. Recent literature continues to reinforce the diagnostic criteria of SSPE including its pathognomonic EEG findings and CSF antibody profile. Despite various treatment trials, no consistently effective therapy has emerged, and current efforts focus on prevention through vaccination and supportive care measures.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "HIV patient MRI typical for Neurocystcercosis, what is the cause?",
    "option_a": "Tinea solium.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval form of Taenia solium, the pork tapeworm. Humans acquire cysticercosis by ingesting eggs from contaminated food or water, which then migrate hematogenously to the central nervous system. After ingestion, T. solium eggs hatch in the intestine. The released oncospheres cross the intestinal wall and travel via the bloodstream to lodge in the brain, where they develop into cysts. MRI typically shows cystic lesions with an eccentric nodule (the scolex), sometimes with surrounding edema and ring enhancement during the inflammatory phase. Patients can present with seizures, headaches, focal neurological deficits, or signs of increased intracranial pressure depending on the cysts\u2019 location and number. In HIV patients, the immunocompromised state may alter presentations, but the classic imaging findings remain a key diagnostic clue. Diagnosis is based on neuroimaging (MRI and CT) and serologic testing (such as the enzyme-linked immunoelectrotransfer blot [EITB]). Differential diagnoses include tuberculomas, toxoplasmosis (especially in HIV), brain abscesses, and metastatic lesions. The presence of a cyst with an eccentric scolex is highly specific for neurocysticercosis. The first-line treatment usually involves antiparasitic agents such as Albendazole, often in combination with corticosteroids to reduce the inflammatory response associated with cyst degeneration. Antiepileptic drugs are used for seizure control. In pregnant patients, risks and benefits are carefully weighed; corticosteroids and Albendazole are used cautiously with close monitoring, while in lactating women, drug transfer through breast milk is considered and alternative management strategies might be employed if appropriate. Option A (Tinea solium) is intended to refer to Taenia solium, the correct causative organism. The other options are not provided, making Option A the proper choice by context. 1. The presence of a cyst with an eccentric scolex on MRI is virtually pathognomonic for neurocysticercosis. 2. Neurocysticercosis is a leading cause of acquired epilepsy in endemic regions. 3. Combination therapy with antiparasitic and steroid treatment is crucial to reducing inflammation and symptomatic seizures. Recent research supports shorter courses of antiparasitic therapy combined with corticosteroids to minimize adverse inflammatory responses. Updated guidelines from organizations such as the CDC and WHO continue to endorse Albendazole as the primary treatment, with an emphasis on tailored therapy based on cyst stage and patient immune status.",
    "exam_year": "2021",
    "exam_type": "Part II"
  }
]